SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Inspire Veterinary Partners, Inc. – ‘10-K’ for 12/31/23 – ‘EX-97.1’

On:  Monday, 4/8/24, at 4:56pm ET   ·   For:  12/31/23   ·   Accession #:  1213900-24-31220   ·   File #:  1-41792

12 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/08/24  Inspire Veterinary Partners, Inc. 10-K       12/31/23   84:8.8M                                   EdgarAgents LLC/FA

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.75M 
 2: EX-4.8      Description of Registrant's Securities              HTML     23K 
 7: EX-97.1     Inspire Veterinary Partners Inc. Incentive          HTML     37K 
                Compensation Recovery Policy                                     
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     24K 
13: R1          Cover                                               HTML    100K 
14: R2          Audit Information                                   HTML     28K 
15: R3          Consolidated Balance Sheets                         HTML    143K 
16: R4          Consolidated Balance Sheets (Parentheticals)        HTML     48K 
17: R5          Consolidated Statements of Operations               HTML    107K 
18: R6          Consolidated Statements of Operations               HTML     31K 
                (Parentheticals)                                                 
19: R7          Consolidated Statements of Changes in               HTML    102K 
                Stockholders? Equity (Deficit)                                   
20: R8          Consolidated Statements of Cash Flows               HTML    146K 
21: R9          Description of Business                             HTML     32K 
22: R10         Significant Accounting Policies and Basis of        HTML     67K 
                Presentation                                                     
23: R11         Property and Equipment                              HTML     32K 
24: R12         Goodwill and Intangible Assets                      HTML     34K 
25: R13         Business Acquisitions                               HTML    104K 
26: R14         Debt                                                HTML    101K 
27: R15         Related Party Transactions                          HTML     36K 
28: R16         Stockholders' Equity                                HTML     39K 
29: R17         Retirement Plan                                     HTML     30K 
30: R18         Income Taxes                                        HTML     44K 
31: R19         Leases                                              HTML     43K 
32: R20         Commitments and Contingencies                       HTML     42K 
33: R21         Subsequent Events                                   HTML     39K 
34: R22         Pay vs Performance Disclosure                       HTML     35K 
35: R23         Insider Trading Arrangements                        HTML     29K 
36: R24         Accounting Policies, by Policy (Policies)           HTML    128K 
37: R25         Significant Accounting Policies and Basis of        HTML     32K 
                Presentation (Tables)                                            
38: R26         Property and Equipment (Tables)                     HTML     30K 
39: R27         Goodwill and Intangible Assets (Tables)             HTML     37K 
40: R28         Business Acquisitions (Tables)                      HTML     76K 
41: R29         Debt (Tables)                                       HTML     78K 
42: R30         Income Taxes (Tables)                               HTML     45K 
43: R31         Leases (Tables)                                     HTML     44K 
44: R32         Significant Accounting Policies and Basis of        HTML     57K 
                Presentation (Details)                                           
45: R33         Significant Accounting Policies and Basis of        HTML     42K 
                Presentation (Details) - Schedule of Estimated                   
                Useful Lives                                                     
46: R34         Significant Accounting Policies and Basis of        HTML     29K 
                Presentation (Details) - Schedule of Diluted Net                 
                Loss Per Share Antidilutive                                      
47: R35         Property and Equipment (Details)                    HTML     25K 
48: R36         Property and Equipment (Details) - Schedule of      HTML     45K 
                Property and Equipment                                           
49: R37         Goodwill and Intangible Assets (Details)            HTML     26K 
50: R38         Goodwill and Intangible Assets (Details) -          HTML     29K 
                Schedule of Carrying Amount of Goodwill                          
51: R39         Goodwill and Intangible Assets (Details) -          HTML     38K 
                Schedule of Intangible Assets                                    
52: R40         Goodwill and Intangible Assets (Details) -          HTML     37K 
                Schedule of Future Amortization Expense of                       
                Intangible Assets                                                
53: R41         Business Acquisitions (Details) - Part 1            HTML     84K 
54: R42         Business Acquisitions (Details) - Part 2            HTML     84K 
55: R43         Business Acquisitions (Details) - Part 4            HTML     68K 
56: R44         Business Acquisitions (Details) - Schedule of       HTML    118K 
                Final Purchase Price Allocation                                  
57: R45         Business Acquisitions (Details) - Schedule of       HTML     28K 
                Unaudited Pro Forma Consolidated Results of                      
                Revenue and Net Loss, Assuming the Acquisitions                  
58: R46         Debt (Details) - Part-1                             HTML     92K 
59: R47         Debt (Details) - Part-2                             HTML    107K 
60: R48         Debt (Details) - Part-3                             HTML    149K 
61: R49         Debt (Details) - Part-4                             HTML     76K 
62: R50         Debt (Details) - Part-5                             HTML     62K 
63: R51         Debt (Details) - Schedule of Long-Term Debt         HTML    119K 
                Instruments                                                      
64: R52         Debt (Details) - Schedule of Long-Term Debt         HTML     84K 
                Instruments                                                      
65: R53         Debt (Details) - Schedule of Tabular Form of Notes  HTML     40K 
                Payable                                                          
66: R54         Debt (Details) - Schedule of Tabular Form of        HTML     40K 
                Maturities of Notes Payable                                      
67: R55         Debt (Details) - Schedule of Bridge Notes           HTML     42K 
68: R56         Related Party Transactions (Details)                HTML     55K 
69: R57         Stockholders' Equity (Details)                      HTML    105K 
70: R58         Retirement Plan (Details)                           HTML     29K 
71: R59         Income Taxes (Details)                              HTML     34K 
72: R60         Income Taxes (Details) - Schedule of Deferred Tax   HTML     50K 
                Assets and Liabilities                                           
73: R61         Income Taxes (Details) - Schedule of U.S Federal    HTML     42K 
                Income Tax Rate                                                  
74: R62         Income Taxes (Details) - Schedule of Income Tax     HTML     28K 
                Benefit                                                          
75: R63         Leases (Details) - Schedule of Consolidated         HTML     40K 
                Statements of Operations                                         
76: R64         Leases (Details) - Schedule of Consolidated         HTML     32K 
                Balance Sheets                                                   
77: R65         Leases (Details) - Schedule of Future Minimum       HTML     42K 
                Lease Payments                                                   
78: R66         Commitments and Contingencies (Details)             HTML     76K 
79: R67         Subsequent Events (Details)                         HTML    110K 
81: XML         IDEA XML File -- Filing Summary                      XML    152K 
84: XML         XBRL Instance -- ea0202969-10k_inspire_htm           XML   1.83M 
80: EXCEL       IDEA Workbook of Financial Report Info              XLSX    198K 
 9: EX-101.CAL  XBRL Calculations -- ivp-20231231_cal                XML    138K 
10: EX-101.DEF  XBRL Definitions -- ivp-20231231_def                 XML   1.18M 
11: EX-101.LAB  XBRL Labels -- ivp-20231231_lab                      XML   2.03M 
12: EX-101.PRE  XBRL Presentations -- ivp-20231231_pre               XML   1.09M 
 8: EX-101.SCH  XBRL Schema -- ivp-20231231                          XSD    294K 
82: JSON        XBRL Instance as JSON Data -- MetaLinks              633±   882K 
83: ZIP         XBRL Zipped Folder -- 0001213900-24-031220-xbrl      Zip    507K 


‘EX-97.1’   —   Inspire Veterinary Partners Inc. Incentive Compensation Recovery Policy


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 97.1

 

Inspire Veterinary Partners Inc.

Incentive Compensation Recovery Policy

 

Effective Date: December 1, 2023

 

1.Purpose. The purpose of the Inspire Veterinary Partners Inc. Incentive Compensation Recovery Policy (this “Policy”) is to provide for the recovery of certain Incentive-Based Compensation in the event of an Accounting Restatement. This Policy is intended to comply with, and to be administered and interpreted consistent with, Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rule 10D-1 promulgated under the Exchange Act (“Rule 10D-1”), and Listing Rule 5608 adopted by the Nasdaq Stock Market LLC (“Nasdaq”) (the “Listing Standards”). Unless otherwise defined in this Policy, capitalized terms shall have the meanings set forth in the Appendix attached hereto.

 

2.Policy for Recovery of Erroneously Awarded Compensation. In the event of an Accounting Restatement, it is the Company’s policy to recover reasonably promptly the amount of any Erroneously Awarded Compensation Received during the Recovery Period.

 

3.Application of Policy. This Policy applies to Incentive-Based Compensation Received by an Executive Officer (i) on or after October 2, 2023 and after such individual began service as an Executive Officer, (ii) if that person served as an Executive Officer at any time during the performance period for the Incentive-Based Compensation, and (iii) while the Company had a listed class of securities on a national securities exchange.

 

4.Administration

 

a.This Policy shall be administered by the Compensation Committee, except that the Board may determine to act as the administrator or designate another committee of the Board to act as the administrator with respect to any portion of this Policy other than Section 4(c) (the “Administrator”). The Administrator is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy.

 

b.The Company is authorized to take appropriate steps to implement this Policy and may effect recovery hereunder by: (i) requiring payment to the Company, (ii) set-off, (iii) reducing compensation, or (iv) such other means or combination of means as the Administrator determines to be appropriate.

 

c.The Company need not recover Erroneously Awarded Compensation if and to the extent that the Compensation Committee or a majority of the independent members of the Board determines that such recovery is impracticable and not required under Rule 10D-1 and the Listing Standards, including if the Compensation Committee or a majority of the independent members of the Board determines that: (i) the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered after making a reasonable attempt to recover, or (ii) recovery would likely cause an otherwise tax-qualified broad-based retirement plan to fail the requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code of 1986, as amended, and regulations thereunder.

 

 

 

 

d.The Administrator may require each Executive Officer to sign and return to the Company an Acknowledgment Form substantially in the form attached to this Policy as Exhibit A or in such other form determined by the Administrator, pursuant to which the Executive Officer agrees to be bound by, and comply with, the terms of this Policy.

 

e.Any determinations made by the Administrator under this Policy shall be final and binding on all affected individuals and need not be uniform among affected individuals.

 

5.Other Recovery Rights; Company Claims. Any right of recovery pursuant to this Policy is in addition to, and not in lieu of, any other remedies or rights of recovery that may be available to the Company under applicable law or pursuant to the terms of any compensation recovery policy in any employment agreement, plan or award agreement, or pursuant to the terms of any other compensation recovery policy of the Company. Nothing contained in this Policy and no recovery hereunder shall limit any claims, damages, or other legal remedies the Company may have against an individual arising out of or resulting from any actions or omissions by such individual.

 

6.Reporting and Disclosure. The Company shall file all disclosures with respect to this Policy in accordance with the requirements of federal securities laws.

 

7.Indemnification Prohibition. Notwithstanding the terms of any indemnification or insurance policy or any contractual arrangement that may be interpreted to the contrary, the Company shall not indemnify any Executive Officer with respect to amount(s) recovered under this Policy or claims relating to the enforcement of this Policy, including any payment or reimbursement for the cost of third-party insurance purchased by such Executive Officer to fund potential clawback obligations hereunder.

 

8.Amendment; Termination. The Board or the Compensation Committee may amend or terminate this Policy from time to time in its discretion as it deems appropriate and shall amend this policy as it deems necessary to comply with applicable law or any rules or standards adopted by a national securities exchange on which the Company’s securities are listed; provided, however, that no amendment or termination of this Policy shall be effective to the extent it would cause the Company to violate any federal securities laws, Securities and Exchange Commission rule or the rules or standards of any national securities exchange on which the Company’s securities are listed.

 

9.Successors. This Policy shall be binding and enforceable against all individuals who are or were Executive Officers and their beneficiaries, heirs, executors, administrators, or other legal representatives.

 

10.Effective Date. This Policy was approved on November      , 2023 and is effective only for Incentive-Based Compensation Received on or after October 2, 2023.

 

2

 

 

APPENDIX

 

Definitions: For purposes of this Policy, the following terms shall have the meanings set forth below:

 

Accounting Restatement” means an accounting restatement of the Company’s financial statements due to the Company’s material noncompliance with any financial reporting requirement under the securities laws, including any accounting restatement required to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.

 

Administrator” has the meaning set forth in Section 4(a) hereof.

 

Board” means the Company’s Board of Directors.

 

Company” means Inspire Veterinary Partners Inc., a corporation organized under the laws of the State of Nevada, and its affiliates.

 

“Compensation Committee” means the Compensation Committee of the Board.

 

Erroneously Awarded Compensation” means the amount, as determined by the Administrator, of Incentive-Based Compensation received by an Executive Officer that exceeds the amount of Incentive-Based Compensation that would have been received by the Executive Officer had it been determined based on the restated amounts. For Incentive-Based Compensation based on stock price or total shareholder return (“TSR”) the Administrator will determine the amount based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or TSR upon which the Incentive-Based Compensation was received, and the Company will maintain documentation of the determination of that reasonable estimate and provide the documentation to Nasdaq. In all cases, the amount to be recovered will be calculated without regard to any taxes paid by the Executive Officer with respect of the Erroneously Awarded Compensation.

 

Executive Officers” means the Company’s current and former executive officers as determined by the Administrator in accordance with Rule 10D-1 and the Listing Standards. Generally, Executive Officers include any executive officer designated by the Board as an “officer” under Rule 16a-1(f) under the Exchange Act.

 

Financial Reporting Measure” means (i) any measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements and any measure derived wholly or in part from such a measure, and (ii) any measure based wholly or in part on the Company’s stock price or total shareholder return. A Financial Reporting Measure need not be presented within the Company’s financial statements or included in a filing with the Securities and Exchange Commission.

 

Incentive-Based Compensation” means any compensation granted, earned, or vested based in whole or in part on the Company’s attainment of a Financial Reporting Measure. Incentive-Based Compensation is deemed to be “Received” for purposes of this Policy in the fiscal period during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant of such Incentive-Based Compensation occurs after the end of that period.

 

Recovery Period” means the three completed fiscal years immediately preceding the date that the Company is required to prepare the applicable Accounting Restatement and any “transition period” as described under Rule 10D-1 and the Listing Standards. For purposes of this Policy, the “date that the Company is required to prepare the applicable Accounting Restatement” is the earlier to occur of (i) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement, or (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare an Accounting Restatement.

 

3

 

 

Exhibit A

 

Inspire Veterinary Partners Inc.

Incentive Compensation Recovery Policy

 

ACKNOWLEDGEMENT FORM

 

I, the undersigned, acknowledge and affirm that I have received and reviewed a copy of the Inspire Veterinary Partners Inc. Incentive Compensation Recovery Policy, and agree that: (i) I am and will continue to be subject to the Inspire Veterinary Partners Inc. Incentive Compensation Recovery Policy, as amended from time to time (the “Policy”), (ii) the Policy will apply to me both during and after my employment with the Company, and (iii) I will abide by the terms of the Policy, including, without limitation, by promptly returning any Erroneously Awarded Compensation to the Company to the extent required by, and in a manner determined by the Administrator and permitted by, the Policy. In the event of any inconsistency between the Policy and the terms of any employment agreement or offer letter to which I am a party, or the terms of any compensation plan, program, or agreement under which any compensation has been granted, awarded, earned or paid, the terms of the Policy shall govern.

 

Capitalized terms used but not otherwise defined in this Acknowledgement Form shall have the meanings ascribed to such terms in the Policy.

 

   
  Signature
   
   
  Print Name
 

 

   
  Date

 

4

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:4/8/24
For Period end:12/31/23NT 10-K
12/1/238-K
10/2/23
 List all Filings 


12 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/12/24  Inspire Veterinary Partners, Inc. 8-K:1,3,9   3/06/24   12:264K                                   EdgarAgents LLC/FA
 2/16/24  Inspire Veterinary Partners, Inc. 8-K:1,5,9   1/01/24   11:284K                                   EdgarAgents LLC/FA
 1/31/24  Inspire Veterinary Partners, Inc. S-1                   94:15M                                    EdgarAgents LLC/FA
 1/26/24  Inspire Veterinary Partners, Inc. S-1/A                 91:16M                                    EdgarAgents LLC/FA
 1/04/24  Inspire Veterinary Partners, Inc. S-1         1/05/24   89:12M                                    EdgarAgents LLC/FA
12/06/23  Inspire Veterinary Partners, Inc. 8-K:1,3,9  11/30/23   12:916K                                   EdgarAgents LLC/FA
11/08/23  Inspire Veterinary Partners, Inc. 8-K:2,3,5,810/27/23   14:660K                                   DataTracks Svcs Ltd./FA
10/31/23  Inspire Veterinary Partners, Inc. 8-K:1,3,9  10/25/23   14:1.5M                                   DataTracks Svcs Ltd./FA
 8/23/23  Inspire Veterinary Partners, Inc. S-1/A                  3:9.8M                                   DataTracks Svcs Ltd./FA
 8/02/23  Inspire Veterinary Partners, Inc. S-1/A                  6:3.6M                                   DataTracks Svcs Ltd./FA
 7/17/23  Inspire Veterinary Partners, Inc. S-1/A       7/14/23   14:4.7M                                   DataTracks Svcs Ltd./FA
 5/23/23  Inspire Veterinary Partners, Inc. S-1/A                 43:7M                                     DataTracks Svcs Ltd./FA
Top
Filing Submission 0001213900-24-031220   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 2:10:31.2pm ET